Procter & Gamble (PG) Stock Forecast, Price Target & Predictions
PG Stock Forecast
Procter & Gamble stock forecast is as follows: an average price target of $172.40 (represents a 3.71% upside from PG’s last price of $166.23) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.
PG Price Target
PG Analyst Ratings
Buy
Procter & Gamble Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jan 23, 2025 | Lauren Lieberman | Barclays | $159.00 | $164.74 | -3.48% | -4.35% |
Dec 05, 2024 | Kaumil Gajrawala | Jefferies | $174.00 | $175.69 | -0.96% | 4.67% |
Nov 22, 2024 | Mark Astrachan | Stifel Nicolaus | $167.00 | $176.28 | -5.26% | 0.46% |
Oct 21, 2024 | Bill Chappell | Truist Financial | $180.00 | $169.64 | 6.11% | 8.28% |
Oct 21, 2024 | Nik Modi | RBC Capital | $164.00 | $169.00 | -2.96% | -1.34% |
Oct 21, 2024 | Linda Bolton Weiser | D.A. Davidson | $160.00 | $169.01 | -5.33% | -3.75% |
Oct 21, 2024 | Olivia Tong | Raymond James | $190.00 | $171.28 | 10.93% | 14.30% |
Oct 09, 2024 | Linda Bolton Weiser | D.A. Davidson | $159.00 | $169.27 | -6.07% | -4.35% |
Oct 04, 2024 | Bonnie Herzog | Goldman Sachs | $164.00 | $168.88 | -2.89% | -1.34% |
Sep 30, 2024 | Lauren Lieberman | Barclays | $163.00 | $173.55 | -6.08% | -1.94% |
Sep 23, 2024 | Korinne Wolfmeyer | Piper Sandler | $174.00 | $173.77 | 0.13% | 4.67% |
Sep 16, 2024 | Kevin Grundy | BNP Paribas | $192.00 | $177.02 | 8.46% | 15.50% |
Jul 24, 2024 | Kaumil Gajrawala | Jefferies | $175.00 | $165.93 | 5.47% | 5.28% |
Jul 22, 2024 | Mark Astrachan | Stifel Nicolaus | $161.00 | $167.96 | -4.14% | -3.15% |
Jul 18, 2024 | Robert Ottenstein | Evercore ISI | $183.00 | $169.44 | 8.00% | 10.09% |
Jul 17, 2024 | Steve Powers | Deutsche Bank | $176.00 | $168.53 | 4.43% | 5.88% |
Jun 24, 2024 | Kevin Grundy | BNP Paribas | $187.00 | $168.26 | 11.14% | 12.49% |
Apr 25, 2024 | Chris Graja | Argus Research | $185.00 | $162.88 | 13.58% | 11.29% |
Apr 23, 2024 | Lauren Lieberman | Barclays | $170.00 | $160.54 | 5.89% | 2.27% |
Nov 24, 2023 | Alexia Howard | Bernstein | $40.00 | $151.38 | -73.58% | -75.94% |
Oct 18, 2023 | Dara Mohsenian | Morgan Stanley | $174.00 | $146.26 | 18.97% | 4.67% |
Jan 13, 2023 | Olivia Tong | Raymond James | $170.00 | $150.25 | 13.14% | 2.27% |
Jan 13, 2023 | J.P. Morgan | $150.00 | $149.87 | 0.09% | -9.76% | |
Jan 03, 2023 | Wells Fargo | $168.00 | $150.62 | 11.54% | 1.06% | |
Dec 06, 2022 | Deutsche Bank | $162.00 | $148.47 | 9.11% | -2.54% | |
Nov 16, 2022 | Wells Fargo | $155.00 | $140.49 | 10.33% | -6.76% | |
Nov 15, 2022 | Credit Suisse | $130.00 | $141.66 | -8.23% | -21.80% | |
Oct 12, 2022 | Olivia Tong | Raymond James | $155.00 | $124.43 | 24.57% | -6.76% |
Oct 09, 2022 | Jason English | Goldman Sachs | $143.00 | $124.27 | 15.07% | -13.97% |
Oct 03, 2022 | Wells Fargo | $150.00 | $126.25 | 18.81% | -9.76% | |
Aug 18, 2022 | Lauren Lieberman | Barclays | $154.00 | $149.81 | 2.80% | -7.36% |
Aug 01, 2022 | Truist Financial | $160.00 | $142.60 | 12.20% | -3.75% | |
Jul 21, 2022 | J.P. Morgan | $156.00 | $139.77 | 11.61% | -6.15% | |
Jun 21, 2022 | Deutsche Bank | $157.00 | $135.81 | 15.60% | -5.55% | |
Jun 19, 2022 | Steve Powers | Deutsche Bank | $171.00 | $132.36 | 29.19% | 2.87% |
Jun 06, 2022 | Chris Carey | Wells Fargo | $170.00 | $145.46 | 16.87% | 2.27% |
May 23, 2022 | Barclays | $157.00 | $141.79 | 10.73% | -5.55% | |
Apr 26, 2022 | Kaumil Gajrawala | Credit Suisse | $150.00 | $161.74 | -7.26% | -9.76% |
Apr 22, 2022 | Barclays | $176.00 | $161.39 | 9.05% | 5.88% | |
Apr 21, 2022 | Deutsche Bank | $177.00 | $164.54 | 7.57% | 6.48% | |
Apr 21, 2022 | Raymond James | $180.00 | $163.65 | 9.99% | 8.28% | |
Apr 19, 2022 | Peter Grom | UBS | $160.00 | $158.52 | 0.93% | -3.75% |
Apr 11, 2022 | Olivia Tong | Raymond James | $175.00 | $159.49 | 9.72% | 5.28% |
Apr 01, 2022 | Jason English | Goldman Sachs | $173.00 | $155.09 | 11.55% | 4.07% |
Mar 23, 2022 | Bill Chappell | Truist Financial | $175.00 | $150.82 | 16.03% | 5.28% |
Jan 20, 2022 | Peter Grom | UBS | $163.00 | $162.00 | 0.62% | -1.94% |
Jan 20, 2022 | Dara Mohsenian | Morgan Stanley | $177.00 | $162.00 | 9.26% | 6.48% |
Jan 19, 2022 | Kevin Grundy | Jefferies | $187.00 | $161.13 | 16.06% | 12.49% |
Jan 19, 2022 | Mark Astrachan | Stifel Nicolaus | $148.00 | $161.13 | -8.15% | -10.97% |
Jan 05, 2022 | Christopher Carey | Wells Fargo | $180.00 | $163.33 | 10.21% | 8.28% |
Oct 05, 2021 | Bryan Spillane | Bank of America Securities | $160.00 | $137.73 | 16.17% | -3.75% |
Aug 04, 2021 | Lars Lusebrink | Independent Research | $154.00 | $140.79 | 9.38% | -7.36% |
Aug 02, 2021 | Kaumil Gajrawala | Credit Suisse | $145.00 | $140.25 | 3.39% | -12.77% |
Apr 21, 2021 | Michael Pohn | DZ BANK AG | $119.00 | $133.58 | -10.91% | -28.41% |
Procter & Gamble Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 3 | 19 |
Avg Price Target | $159.00 | $166.67 | $172.79 |
Last Closing Price | $166.23 | $166.23 | $166.23 |
Upside/Downside | -4.35% | 0.26% | 3.95% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jan 23, 2025 | RBC Capital | Sector Perform | Sector Perform | Downgrade |
Jan 23, 2025 | Barclays | Equal-Weight | Equal-Weight | Hold |
Jan 23, 2025 | Wells Fargo | Overweight | Overweight | Hold |
Dec 05, 2024 | Jefferies | Hold | Hold | Hold |
Oct 21, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 21, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 21, 2024 | Piper Sandler | Underperform | Underperform | Hold |
Oct 21, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Oct 21, 2024 | Raymond James | Outperform | Outperform | Hold |
Oct 15, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Oct 09, 2024 | D.A. Davidson | Neutral | Initialise | |
Oct 04, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Sep 30, 2024 | Barclays | Overweight | Equal-Weight | Downgrade |
Sep 23, 2024 | Piper Sandler | Neutral | Initialise | |
Sep 16, 2024 | Exane BNP Paribas | Outperform | Outperform | Hold |
Sep 16, 2024 | BNP Paribas | Outperform | Outperform | Hold |
Jul 31, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Jul 24, 2024 | Jefferies | Hold | Downgrade | |
Jul 22, 2024 | Cowen & Co. | Buy | Initialise | |
Jul 19, 2024 | Barclays | Overweight | Overweight | Hold |
Jul 18, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Jul 17, 2024 | Deutsche Bank | Buy | Buy | Hold |
Jul 10, 2024 | Citigroup | Buy | Buy | Hold |
Jun 24, 2024 | Exane BNP Paribas | Outperform | Initialise | |
Apr 12, 2024 | Barclays | Overweight | Overweight | Hold |
Apr 03, 2024 | Deutsche Bank | Buy | Buy | Hold |
Jan 24, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Nov 24, 2023 | Bernstein | Market Perform | Outperform | Upgrade |
Nov 24, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 19, 2023 | Raymond James | Outperform | Outperform | Hold |
Oct 18, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 18, 2023 | Barclays | Overweight | Overweight | Hold |
Oct 18, 2023 | Bernstein | Market Perform | Market Perform | Hold |
Jul 31, 2023 | Deutsche Bank | Buy | Buy | Hold |
Apr 24, 2023 | Raymond James | Outperform | Outperform | Hold |
Apr 24, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Mar 21, 2023 | J.P. Morgan | Overweight | Upgrade | |
Mar 01, 2023 | RBC Capital | Sector Perform | Downgrade | |
Mar 01, 2023 | Keefe, Bruyette & Woods | Market Perform | Downgrade | |
Mar 01, 2023 | Benchmark | Buy | Upgrade | |
Mar 01, 2023 | Roth Capital | Neutral | Upgrade | |
Mar 01, 2023 | UBS | Buy | Upgrade | |
Jan 13, 2023 | Raymond James | Outperform | Outperform | Hold |
Jan 03, 2023 | Wells Fargo | Overweight | Overweight | Hold |
Dec 06, 2022 | Deutsche Bank | Buy | Buy | Hold |
Nov 16, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Nov 15, 2022 | Credit Suisse | Neutral | Neutral | Hold |
Oct 12, 2022 | Raymond James | Outperform | Outperform | Hold |
Oct 09, 2022 | Goldman Sachs | Buy | Neutral | Downgrade |
Oct 03, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Aug 02, 2022 | Barclays | Overweight | Overweight | Hold |
Jul 25, 2022 | Raymond James | Outperform | Outperform | Hold |
Jun 01, 2022 | Deutsche Bank | Buy | Buy | Hold |
Jun 01, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Apr 26, 2022 | Credit Suisse | Neutral | Neutral | Hold |
Apr 11, 2022 | Raymond James | Outperform | Initialise | |
Apr 01, 2022 | Goldman Sachs | Buy | Buy | Hold |
Jan 23, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Procter & Gamble Financial Forecast
Procter & Gamble Revenue Forecast
Quarter
Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $21.44B | $21.87B | $20.55B | $20.07B | $20.77B | $20.61B | $19.52B | $19.38B | $20.95B | $20.34B | $18.95B | $18.11B |
Avg Forecast | $23.55B | $23.04B | $24.14B | $23.80B | $22.68B | $22.02B | $23.35B | $23.07B | $21.91B | $21.30B | $22.53B | $22.30B | $21.13B | $20.54B | $21.58B | $21.99B | $20.72B | $20.43B | $21.48B | $21.58B | $20.01B | $19.28B | $20.75B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B |
High Forecast | $23.90B | $23.39B | $24.51B | $24.17B | $23.03B | $22.35B | $23.70B | $23.42B | $22.25B | $21.63B | $22.87B | $22.64B | $21.45B | $20.80B | $21.78B | $22.04B | $20.74B | $20.43B | $21.74B | $21.91B | $20.31B | $19.57B | $21.10B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B |
Low Forecast | $23.09B | $22.60B | $23.68B | $23.35B | $22.25B | $21.59B | $22.90B | $22.62B | $21.49B | $20.89B | $22.10B | $21.87B | $20.72B | $20.08B | $21.30B | $21.93B | $20.71B | $20.43B | $21.09B | $21.17B | $19.63B | $18.91B | $20.38B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B |
# Analysts | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 13 | 13 | 8 | 5 | 5 | 11 | 5 | 5 | 10 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.03% | 1.04% | 1.00% | 1.01% | 1.01% | 1.04% | 1.03% | 1.03% | 1.03% | 1.01% |
Forecast
Procter & Gamble EBITDA Forecast
Quarter
Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 13 | 13 | 8 | 5 | 5 | 11 | 5 | 5 | 10 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.43B | $5.77B | $5.18B | $5.20B | $5.01B | $5.78B | $4.49B | $4.18B | $6.01B | $5.84B | $4.39B | $4.69B |
Avg Forecast | $6.34B | $6.20B | $6.50B | $6.41B | $6.10B | $5.93B | $6.28B | $6.21B | $5.90B | $5.73B | $6.06B | $6.00B | $5.69B | $5.53B | $5.81B | $5.92B | $5.58B | $5.70B | $5.78B | $5.81B | $5.39B | $5.18B | $6.57B | $5.51B | $5.25B | $4.71B | $5.50B | $5.36B | $4.97B | $4.41B |
High Forecast | $6.43B | $6.30B | $6.60B | $6.50B | $6.20B | $6.02B | $6.38B | $6.30B | $5.99B | $5.82B | $6.16B | $6.09B | $5.77B | $5.60B | $5.86B | $5.93B | $5.58B | $6.84B | $5.85B | $5.90B | $5.47B | $6.21B | $7.89B | $5.51B | $5.25B | $5.65B | $5.50B | $5.36B | $4.97B | $5.29B |
Low Forecast | $6.22B | $6.08B | $6.37B | $6.28B | $5.99B | $5.81B | $6.16B | $6.09B | $5.79B | $5.62B | $5.95B | $5.89B | $5.58B | $5.41B | $5.73B | $5.90B | $5.57B | $4.56B | $5.68B | $5.70B | $5.28B | $4.14B | $5.26B | $5.51B | $5.25B | $3.77B | $5.50B | $5.36B | $4.97B | $3.53B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.99% | 0.96% | 1.00% | 0.76% | 1.05% | 0.86% | 0.89% | 1.09% | 1.09% | 0.88% | 1.06% |
Forecast
Procter & Gamble Net Income Forecast
Quarter
Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 13 | 13 | 8 | 5 | 5 | 11 | 5 | 5 | 10 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.20M | $4.52B | $3.38B | $3.40B | $3.93B | $3.94B | $3.05B | $3.35B | $4.24B | $4.11B | $2.91B | $3.27B |
Avg Forecast | $4.64B | $4.80B | $5.61B | $5.62B | $4.37B | $4.47B | $5.29B | $5.21B | $4.05B | $4.19B | $4.96B | $4.92B | $3.77B | $3.89B | $4.57B | $4.67B | $3.38B | $3.93B | $4.17B | $4.23B | $3.25B | $3.58B | $4.62B | $3.84B | $3.02B | $3.25B | $4.08B | $3.93B | $2.68B | $3.08B |
High Forecast | $4.73B | $4.89B | $5.72B | $5.73B | $4.46B | $4.55B | $5.40B | $5.31B | $4.13B | $4.27B | $5.06B | $5.02B | $3.84B | $4.01B | $4.67B | $4.68B | $3.42B | $4.72B | $4.22B | $4.31B | $3.32B | $4.29B | $5.54B | $3.84B | $3.11B | $3.90B | $4.08B | $3.93B | $2.77B | $3.69B |
Low Forecast | $4.52B | $4.68B | $5.47B | $5.48B | $4.27B | $4.35B | $5.16B | $5.08B | $3.95B | $4.08B | $4.84B | $4.80B | $3.68B | $3.84B | $4.47B | $4.66B | $3.34B | $3.15B | $4.07B | $4.12B | $3.17B | $2.86B | $3.69B | $3.84B | $2.94B | $2.60B | $4.08B | $3.93B | $2.59B | $2.46B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.07% | 1.04% | 0.95% | 0.85% | 1.03% | 1.01% | 1.03% | 1.04% | 1.05% | 1.08% | 1.06% |
Forecast
Procter & Gamble SG&A Forecast
Quarter
Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 13 | 13 | 8 | 5 | 5 | 11 | 5 | 5 | 10 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.52B | $5.60B | $5.78B | $5.42B | $5.09B | $4.83B | $5.12B | $5.03B | $5.12B | $4.95B | $5.62B | $5.40B |
Avg Forecast | $6.33B | $6.20B | $6.49B | $6.40B | $6.10B | $5.92B | $6.28B | $6.20B | $5.89B | $5.73B | $6.06B | $6.00B | $5.68B | $5.52B | $5.80B | $5.91B | $5.57B | $5.90B | $5.78B | $5.80B | $5.38B | $5.36B | $5.60B | $5.38B | $5.12B | $4.88B | $5.37B | $5.24B | $4.85B | $5.08B |
High Forecast | $6.43B | $6.29B | $6.59B | $6.50B | $6.19B | $6.01B | $6.38B | $6.30B | $5.98B | $5.82B | $6.15B | $6.09B | $5.77B | $5.59B | $5.86B | $5.93B | $5.58B | $7.08B | $5.85B | $5.89B | $5.46B | $6.43B | $6.72B | $5.38B | $5.12B | $5.85B | $5.37B | $5.24B | $4.85B | $6.10B |
Low Forecast | $6.21B | $6.08B | $6.37B | $6.28B | $5.98B | $5.81B | $6.16B | $6.09B | $5.78B | $5.62B | $5.94B | $5.88B | $5.57B | $5.40B | $5.73B | $5.90B | $5.57B | $4.72B | $5.67B | $5.69B | $5.28B | $4.29B | $4.48B | $5.38B | $5.12B | $3.90B | $5.37B | $5.24B | $4.85B | $4.07B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.97% | 1.07% | 1.01% | 0.91% | 0.90% | 1.00% | 1.03% | 0.95% | 0.95% | 1.16% | 1.06% |
Forecast
Procter & Gamble EPS Forecast
Quarter
Jun 28 | Mar 28 | Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 12 | 11 | 10 | 9 | 13 | 13 | 8 | 5 | 5 | 11 | 5 | 5 | 10 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.01 | $1.89 | $1.40 | $1.41 | $1.63 | $1.62 | $1.24 | $1.37 | $1.76 | $1.66 | $1.16 | $1.30 |
Avg Forecast | $1.89 | $1.95 | $2.28 | $2.29 | $1.78 | $1.82 | $2.15 | $2.12 | $1.65 | $1.70 | $2.02 | $2.00 | $1.53 | $1.58 | $1.86 | $1.90 | $1.37 | $1.42 | $1.70 | $1.72 | $1.32 | $1.32 | $1.59 | $1.55 | $1.22 | $1.29 | $1.65 | $1.59 | $1.08 | $1.19 |
High Forecast | $1.92 | $1.99 | $2.33 | $2.33 | $1.81 | $1.85 | $2.19 | $2.16 | $1.68 | $1.74 | $2.06 | $2.04 | $1.56 | $1.63 | $1.90 | $1.90 | $1.39 | $1.42 | $1.72 | $1.75 | $1.35 | $1.38 | $1.62 | $1.55 | $1.26 | $1.36 | $1.65 | $1.59 | $1.12 | $1.19 |
Low Forecast | $1.84 | $1.90 | $2.22 | $2.23 | $1.74 | $1.77 | $2.10 | $2.07 | $1.61 | $1.66 | $1.97 | $1.95 | $1.50 | $1.56 | $1.82 | $1.89 | $1.36 | $1.42 | $1.66 | $1.68 | $1.29 | $1.27 | $1.55 | $1.55 | $1.19 | $1.22 | $1.65 | $1.59 | $1.05 | $1.19 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.10% | 1.06% | 1.07% | 1.03% | 1.04% | 1.01% | 1.06% | 1.07% | 1.04% | 1.07% | 1.09% |
Forecast
Procter & Gamble Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COTY | Coty | $7.26 | $12.50 | 72.18% | Buy |
ELF | e.l.f. Beauty | $105.96 | $154.20 | 45.53% | Buy |
EL | Estée Lauder Companies | $82.28 | $110.60 | 34.42% | Hold |
UL | Unilever | $57.27 | $72.00 | 25.72% | Buy |
CL | Colgate-Palmolive | $89.57 | $110.50 | 23.37% | Buy |
KMB | Kimberly-Clark | $129.67 | $151.00 | 16.45% | Hold |
KVUE | Kenvue | $21.31 | $24.75 | 16.14% | Buy |
PG | Procter & Gamble | $166.23 | $172.40 | 3.71% | Buy |
CLX | Clorox | $157.81 | $159.50 | 1.07% | Hold |
CHD | Church & Dwight | $106.77 | $106.20 | -0.53% | Hold |